KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Other financing activities (2016 - 2025)

Historic Other financing activities for National Health Investors (NHI) over the last 14 years, with Q3 2025 value amounting to $3.6 million.

  • National Health Investors' Other financing activities rose 40898.88% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 68187.27%. This contributed to the annual value of $3.5 million for FY2024, which is 1725.53% up from last year.
  • As of Q3 2025, National Health Investors' Other financing activities stood at $3.6 million, which was up 40898.88% from $138000.0 recorded in Q2 2025.
  • Over the past 5 years, National Health Investors' Other financing activities peaked at $20.6 million during Q2 2022, and registered a low of -$8.8 million during Q1 2022.
  • In the last 5 years, National Health Investors' Other financing activities had a median value of $712000.0 in 2024 and averaged $2.1 million.
  • In the last 5 years, National Health Investors' Other financing activities soared by 3420000.0% in 2021 and then plummeted by 29820.59% in 2022.
  • Over the past 5 years, National Health Investors' Other financing activities (Quarter) stood at $559000.0 in 2021, then skyrocketed by 3580.86% to $20.6 million in 2022, then crashed by 99.75% to $51000.0 in 2023, then soared by 5201.96% to $2.7 million in 2024, then soared by 34.02% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $138000.0 for Q2 2025, and $47000.0 during Q1 2025.